
    
      Title: Diversion-p64. Device: p64 Flow Modulation Device. Study design: Prospective,
      multicenter, single arm Post Market Clinical Follow-Up Study.

      Purpose: To assess safety and effectiveness of p64. Study duration: 48 months. Sample Size:
      400 patients. Number of sites: > 20. Follow-up intervals: Two independent follow-ups (after
      3-6 and 7-12 months) according to site specific standard.
    
  